As CMS discussed in a 2024 Request for Information (RFI) (89 FR 61596), [159] we expect that a more targeted approach where clinicians are evaluated: (1) on required reporting of a set of relevant performance measures
Product Specifications Active Compound: Retatrutide peptide Strength: 30mg per vial Form: Lyophilized powder Reconstitution Required: Yes, according to a validated laboratory protocol Manufacturer, as listed: Novera Compounds Country of Origin, as listed: United States Brand: Novera Intended Use: Laboratory and in vitro research only Package Content: 1 x 30mg vial Weight: 7 grams Dimensions: Width: 20mm | Height: 40mm | Length: 20mm Human-Use Status: Not approved for human use, clinical application, injection, or consumption Researchers should verify the product label, certificate of analysis, batch identity, purity method, storage requirements, safety data sheet, and manufacturer information before use
Intended Use This product is supplied strictly for laboratory research purposes only and is intended for use by qualified professionals in controlled scientific environments
The honest, educational picture is more nuanced